Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2016

Open Access 01-12-2016 | Research

The rare and undiagnosed diseases diagnostic service – application of massively parallel sequencing in a state-wide clinical service

Authors: Gareth Baynam, Nicholas Pachter, Fiona McKenzie, Sharon Townshend, Jennie Slee, Cathy Kiraly-Borri, Anand Vasudevan, Anne Hawkins, Stephanie Broley, Lyn Schofield, Hedwig Verhoef, Caroline E. Walker, Caron Molster, Jenefer M. Blackwell, Sarra Jamieson, Dave Tang, Timo Lassmann, Kym Mina, John Beilby, Mark Davis, Nigel Laing, Lesley Murphy, Tarun Weeramanthri, Hugh Dawkins, Jack Goldblatt

Published in: Orphanet Journal of Rare Diseases | Issue 1/2016

Login to get access

Abstract

Background

The Rare and Undiagnosed Diseases Diagnostic Service (RUDDS) refers to a genomic diagnostic platform operating within the Western Australian Government clinical services delivered through Genetic Services of Western Australia (GSWA). GSWA has provided a state-wide service for clinical genetic care for 28 years and it serves a population of 2.5 million people across a geographical area of 2.5milion Km2. Within this context, GSWA has established a clinically integrated genomic diagnostic platform in partnership with other public health system managers and service providers, including but not limited to the Office of Population Health Genomics, Diagnostic Genomics (PathWest Laboratories) and with executive level support from the Department of Health. Herein we describe report presents the components of this service that are most relevant to the heterogeneity of paediatric clinical genetic care.

Results

Briefly the platform : i) offers multiple options including non-genetic testing; monogenic and genomic (targeted in silico filtered and whole exome) analysis; and matchmaking; ii) is delivered in a patient-centric manner that is resonant with the patient journey, it has multiple points for entry, exit and re-entry to allow people access to information they can use, when they want to receive it; iii) is synchronous with precision phenotyping methods; iv) captures new knowledge, including multiple expert review; v) is integrated with current translational genomic research activities and best practice; and vi) is designed for flexibility for interactive generation of, and integration with, clinical research for diagnostics, community engagement, policy and models of care.

Conclusion

The RUDDS has been established as part of routine clinical genetic services and is thus sustainable, equitably managed and seeks to translate new knowledge into efficient diagnostics and improved health for the whole community.
Literature
1.
go back to reference Ayme S, Rodwell C., eds. 2013 Report on the state of the art of rare disease activities in Europe. EUCERD, 2013 Ayme S, Rodwell C., eds. 2013 Report on the state of the art of rare disease activities in Europe. EUCERD, 2013
2.
go back to reference European Organisation for Rare Diseases. Rare Diseases: understanding this public health priority. EURORDIS, 2005. European Organisation for Rare Diseases. Rare Diseases: understanding this public health priority. EURORDIS, 2005.
3.
go back to reference Remuzzi G, Garattini S. Rare diseases: what's next? Lancet (London, England). 2008;371(9629):1978–9.CrossRef Remuzzi G, Garattini S. Rare diseases: what's next? Lancet (London, England). 2008;371(9629):1978–9.CrossRef
4.
go back to reference Schieppati A, Henter JI, Daina E, Aperia A. Why rare diseases are an important medical and social issue. Lancet (London, England. 2008;371(9629):2039–41.CrossRef Schieppati A, Henter JI, Daina E, Aperia A. Why rare diseases are an important medical and social issue. Lancet (London, England. 2008;371(9629):2039–41.CrossRef
5.
go back to reference European Organisation for Rare Diseases. Survey of the delay in diagnosis for 8 rare diseases in Europe (EurordisCare2). EURORDIS Fact sheets, 2007. European Organisation for Rare Diseases. Survey of the delay in diagnosis for 8 rare diseases in Europe (EurordisCare2). EURORDIS Fact sheets, 2007.
6.
go back to reference Molster C, Urwin D, Di Pietro L, Fookes M, Petrie D, van der Laan S, et al. Survey of healthcare experiences of Australian adults living with rare diseases. Orphanet J Rare Dis. 2016;11:30.CrossRefPubMedPubMedCentral Molster C, Urwin D, Di Pietro L, Fookes M, Petrie D, van der Laan S, et al. Survey of healthcare experiences of Australian adults living with rare diseases. Orphanet J Rare Dis. 2016;11:30.CrossRefPubMedPubMedCentral
8.
go back to reference Lee H, Deignan JL, Dorrani N, Strom SP, Kantarci S, Quintero-Rivera F, et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA. 2014;312(18):1880–7.CrossRefPubMedPubMedCentral Lee H, Deignan JL, Dorrani N, Strom SP, Kantarci S, Quintero-Rivera F, et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA. 2014;312(18):1880–7.CrossRefPubMedPubMedCentral
9.
go back to reference Yang Y, Muzny DM, Xia F, Niu Z, Person R, Ding Y, et al. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA. 2014;312(18):1870–9.CrossRefPubMedPubMedCentral Yang Y, Muzny DM, Xia F, Niu Z, Person R, Ding Y, et al. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA. 2014;312(18):1870–9.CrossRefPubMedPubMedCentral
10.
go back to reference Retterer K, Juusola J, Cho MT, Vitazka P, Millan F, Gibellini F, et al. Clinical application of whole-exome sequencing across clinical indications. Genet Med. Epub Dec. 2015 Retterer K, Juusola J, Cho MT, Vitazka P, Millan F, Gibellini F, et al. Clinical application of whole-exome sequencing across clinical indications. Genet Med. Epub Dec. 2015
11.
go back to reference Atwal PS, Brennan ML, Cox R, Niaki M, Platt J, Homeyer M, et al. Clinical whole-exome sequencing: are we there yet? Genet Med. 2014;16(9):717–9.CrossRefPubMed Atwal PS, Brennan ML, Cox R, Niaki M, Platt J, Homeyer M, et al. Clinical whole-exome sequencing: are we there yet? Genet Med. 2014;16(9):717–9.CrossRefPubMed
12.
go back to reference Tang D, Anderson D, Francis RW, Syn G, Jamieson SE, Lassmann T, et al. Reference genotype and exome data from an Australian Aboriginal population for health-based research. Scientific Data. 2016;3:160023.CrossRefPubMedPubMedCentral Tang D, Anderson D, Francis RW, Syn G, Jamieson SE, Lassmann T, et al. Reference genotype and exome data from an Australian Aboriginal population for health-based research. Scientific Data. 2016;3:160023.CrossRefPubMedPubMedCentral
13.
go back to reference Baynam G, Overkov A, Davis M, Mina K, Schofield L, Allcock R, et al. A germline MTOR mutation in Aboriginal Australian siblings with intellectual disability, dysmorphism, macrocephaly, and small thoraces. Am J Med Genetics Part A. 2015;167(7):1659–67.CrossRef Baynam G, Overkov A, Davis M, Mina K, Schofield L, Allcock R, et al. A germline MTOR mutation in Aboriginal Australian siblings with intellectual disability, dysmorphism, macrocephaly, and small thoraces. Am J Med Genetics Part A. 2015;167(7):1659–67.CrossRef
14.
go back to reference Groza T, Kohler S, Doelken S, Collier N, Oellrich A, Smedley D, et al. Automatic concept recognition using the human phenotype ontology reference and test suite corpora. Database (Oxford). 2015;2015:1.CrossRef Groza T, Kohler S, Doelken S, Collier N, Oellrich A, Smedley D, et al. Automatic concept recognition using the human phenotype ontology reference and test suite corpora. Database (Oxford). 2015;2015:1.CrossRef
15.
go back to reference Taruscio D, Groft SC, Cederroth H, Melegh B, Lasko P, Kosaki K, et al. Undiagnosed Diseases Network International (UDNI): White paper for global actions to meet patient needs. Molecular genetics and metabolism. 2015;116(4):223–5.CrossRefPubMed Taruscio D, Groft SC, Cederroth H, Melegh B, Lasko P, Kosaki K, et al. Undiagnosed Diseases Network International (UDNI): White paper for global actions to meet patient needs. Molecular genetics and metabolism. 2015;116(4):223–5.CrossRefPubMed
Metadata
Title
The rare and undiagnosed diseases diagnostic service – application of massively parallel sequencing in a state-wide clinical service
Authors
Gareth Baynam
Nicholas Pachter
Fiona McKenzie
Sharon Townshend
Jennie Slee
Cathy Kiraly-Borri
Anand Vasudevan
Anne Hawkins
Stephanie Broley
Lyn Schofield
Hedwig Verhoef
Caroline E. Walker
Caron Molster
Jenefer M. Blackwell
Sarra Jamieson
Dave Tang
Timo Lassmann
Kym Mina
John Beilby
Mark Davis
Nigel Laing
Lesley Murphy
Tarun Weeramanthri
Hugh Dawkins
Jack Goldblatt
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2016
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-016-0462-7

Other articles of this Issue 1/2016

Orphanet Journal of Rare Diseases 1/2016 Go to the issue